LEADER 01783nam 2200493 450 001 9910713499803321 005 20200414150658.0 035 $a(CKB)5470000002500651 035 $a(OCoLC)1150786029 035 $a(EXLCZ)995470000002500651 100 $a20200414d2009 ua 0 101 0 $aeng 135 $aurbn||||||||| 181 $ctxt$2rdacontent 182 $cc$2rdamedia 183 $acr$2rdacarrier 200 10$aOperation Anaconda $elessons for Joint Operations /$fRichard Kugler, Michael Baranick, and Hans Binnendijk 210 1$a[Washington, D.C.] :$cCenter for Technology and National Security Policy, National Defense University,$d2009. 215 $a1 online resource (xiv, 59 pages) $ccolor illustrations 225 1 $aDefense & technology paper ;$vno. 60 300 $a"March 2009." 300 $aSeries information from agency website. 517 $aOperation Anaconda 606 $aOperation Anaconda, 2002 606 $aAfghan War, 2001-2021 606 $aMilitary planning$zUnited States$xEvaluation 606 $aNational security$zAfghanistan 606 $aUnified operations (Military science) 607 $aUnited States$xArmed Forces$xOperational readiness 615 0$aOperation Anaconda, 2002. 615 0$aAfghan War, 2001-2021. 615 0$aMilitary planning$xEvaluation. 615 0$aNational security 615 0$aUnified operations (Military science) 700 $aKugler$b Richard L.$01087679 702 $aBaranick$b Michael 702 $aBinnendijk$b Hans 712 02$aNational Defense University.$bCenter for Technology and National Security Policy, 801 0$bGPO 801 1$bGPO 906 $aBOOK 912 $a9910713499803321 996 $aOperation Anaconda$93511268 997 $aUNINA LEADER 05283nam 2201669z- 450 001 9910585940103321 005 20220812 035 $a(CKB)5600000000483081 035 $a(oapen)https://directory.doabooks.org/handle/20.500.12854/91187 035 $a(oapen)doab91187 035 $a(EXLCZ)995600000000483081 100 $a20202208d2022 |y 0 101 0 $aeng 135 $aurmn|---annan 181 $ctxt$2rdacontent 182 $cc$2rdamedia 183 $acr$2rdacarrier 200 00$aPharmacy Practice and Administration 210 $aBasel$cMDPI - Multidisciplinary Digital Publishing Institute$d2022 215 $a1 online resource (260 p.) 311 08$a3-0365-4730-4 311 08$a3-0365-4729-0 330 $aThe scope of the Special Issue is research and reviews on evaluations of current practice, innovations in medication management, developments in therapeutics, and pharmaceutical science research that informs and improves practice and administration, as well as the social and administrative pharmacy. We will mainly feature original research, reviews, short reports, and clinical studies, but also case reports, descriptive/how-to, and commentary submissions for consideration. 606 $aManufacturing industries$2bicssc 606 $aMedicine and Nursing$2bicssc 610 $aability 610 $aabuse 610 $aacute care 610 $aadditional monitoring 610 $aadolescents and young adults 610 $aadverse drug events 610 $aadverse event reporting 610 $aambulatory care facilities 610 $aantimicrobial resistance (AMR) 610 $aasynchronous learning 610 $aattitudes 610 $aavailability 610 $aawareness 610 $abarriers 610 $abiosensing technology 610 $ablack triangle 610 $abusiness 610 $acancer patients 610 $aChief Pharmaceutical Officer's Global Health Fellowship 610 $aCommonwealth Partnerships for Antimicrobial Stewardship (CwPAMS) 610 $acommunity pharmacies 610 $acommunity pharmacists 610 $acommunity pharmacy 610 $acommunity pharmacy services 610 $acontraception 610 $aCOVID-19 610 $aCPhOGH Fellows 610 $aCwPAMS 610 $adecision to study in pharmacy 610 $adefined daily dose 610 $adigital medicine system 610 $adrug disposal 610 $adrug-related problems 610 $ae-prescription 610 $aemergency contraception 610 $aemergency contraceptives 610 $aemergency prescribing 610 $aentrepreneurship 610 $aenvironment 610 $afellowship 610 $afinancial management 610 $afragility 610 $aGermany 610 $aglobal health 610 $ahealth partnerships 610 $ahealth workforce 610 $ahigh fidelity 610 $ainformation gathering 610 $ainternal medicine ward 610 $ainterprofessional 610 $aintervention 610 $aJazan 610 $aleadership 610 $alearning activity 610 $alevonorgestrel 610 $aMedicaid 610 $aMedicare 610 $amedication adherence 610 $amedication event monitoring system 610 $amedication review 610 $amedication safety 610 $amedication-related problems 610 $amedicine consumption 610 $amortality 610 $aMUR 610 $amystery calls 610 $aNational Health Service (NHS) 610 $anon-prescription medicines 610 $anonadherence 610 $anursing 610 $aolder adults 610 $aoutcomes 610 $apain 610 $apatient education 610 $aperception 610 $apharmacist 610 $apharmacists 610 $apharmacogenomics 610 $apharmacovigilance 610 $apharmacy 610 $apharmacy education 610 $apharmacy law and regulation 610 $apharmacy management 610 $apharmacy practice 610 $apharmacy students 610 $apolypharmacy 610 $apractice 610 $apregabalin 610 $aprescription errors 610 $aprescription opioids 610 $aprescription writing 610 $aprescriptions 610 $apricing 610 $aProgram of All-Inclusive Care for the Elderly 610 $areproductive health 610 $aSaudi Arabia 610 $aselecting pharmacy as a first choice 610 $asimulation 610 $aSPICE-R2 610 $astandardized mortality ratio 610 $astandardized patients 610 $astudent survey 610 $astudents 610 $asystematic review 610 $aTaiwan 610 $aulipristal acetate 610 $aunderlying cause of death 610 $aunused medication 610 $avirtual learning 615 7$aManufacturing industries 615 7$aMedicine and Nursing 700 $aAdunlin$b Georges$4edt$01328216 702 $aAdunlin$b Georges$4oth 906 $aBOOK 912 $a9910585940103321 996 $aPharmacy Practice and Administration$93038436 997 $aUNINA